Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (PINL:NVIVQ)

InVivo Therapeutics Announces Enrollment of Third Patient in Pilot Spinal Cord Injury Trial

Business Wire June 5, 2015

InVivo Therapeutics' Neuro-Spinal Scaffold Featured on NBC's TODAY Show

Business Wire June 3, 2015

InVivo Therapeutics' Neuro-Spinal Scaffold Receives 2015 Becker's Healthcare Spine Device Award

Business Wire June 1, 2015

InVivo Therapeutics Announces Indiana's Goodman Campbell Brain and Spine as New Site for Neuro-Spinal Scaffold Clinical Trial

Business Wire May 19, 2015

InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold

Business Wire May 14, 2015

InVivo Therapeutics Reports 2015 First Quarter Financial Results and Business Update

Business Wire May 7, 2015

InVivo Therapeutics to Exhibit at the 83rd AANS Annual Scientific Meeting

Business Wire May 1, 2015

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire April 16, 2015

InVivo Therapeutics Announces Uplisting to Nasdaq

Business Wire April 16, 2015

InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold

Business Wire April 1, 2015

InVivo Therapeutics Announces University of Kansas Medical Center as New Site for Neuro-Spinal Scaffold Clinical Trial

Business Wire March 30, 2015

InVivo Therapeutics Exhibiting at 66th Southern Neurosurgical Society Annual Meeting

Business Wire March 27, 2015

InVivo Therapeutics Announces Reopening of Enrollment for Subjects Three through Five for Anticipated Completion of Ongoing Pilot Trial

Business Wire March 26, 2015

InVivo Therapeutics Announces Keck Hospital of University of Southern California as New Site for Neuro-Spinal Scaffold Clinical Trial

Business Wire March 25, 2015

InVivo Therapeutics Announces Reverse Stock Split in Preparation for Planned Uplisting to NASDAQ

Business Wire March 24, 2015

InVivo Therapeutics Reports 2014 Year End Financial Results and Business Update

Business Wire March 11, 2015

InVivo Therapeutics Announces Froedtert & the Medical College of Wisconsin as New Clinical Trial Site for Neuro-Spinal Scaffold

Business Wire February 23, 2015

InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer

Business Wire February 9, 2015

InVivo Therapeutics Announces CEO Mark Perrin Named Chairman of the Board

Business Wire February 5, 2015

InVivo Therapeutics Announces $12 Million Registered Direct Offering

Business Wire January 29, 2015